Anticancer Research

Papers
(The H4-Index of Anticancer Research is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Role of Oncogenes and Tumor-suppressor Genes in Carcinogenesis: A Review147
Second-line Treatment in Advanced Biliary Tract Cancer: Today and Tomorrow56
Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer: Review of the Literature and Perspectives of Clinical Research55
Oncogenic miRNAs Identified in Tear Exosomes From Metastatic Breast Cancer Patients55
Delay in Breast Cancer Treatments During the First COVID-19 Lockdown. A Multicentric Analysis of 432 Patients49
Artificial Intelligence in Ovarian Cancer Diagnosis47
Cytokine-based Cancer Immunotherapy: Challenges and Opportunities for IL-1044
Gene Polymorphisms and Circulating Levels of MMP-2 and MMP-9: A Review of Their Role in Breast Cancer Risk39
Chemoradiotherapy in Cancer Treatment: Rationale and Clinical Applications39
Skeletal Muscle Mass Change During Chemotherapy: A Systematic Review and Meta-analysis38
The Development of Next-generation PBMC Humanized Mice for Preclinical Investigation of Cancer Immunotherapeutic Agents38
The Role of MSCs in the Tumor Microenvironment and Tumor Progression36
Anti-infectious and Anti-tumor Activities of β-glucans35
Quercetin Suppresses Proliferation of Liver Cancer Cell Lines In Vitro35
Fecal Occult Blood Tests in Colorectal Cancer Screening: Systematic Review and Meta-analysis of Traditional and New-generation Fecal Immunochemical Tests33
Savi Scout® Radar Localisation of Non-palpable Breast Lesions: Systematic Review and Pooled Analysis of 842 Cases32
Systematic Review on the Controlling Nutritional Status (CONUT) Score in Patients Undergoing Esophagectomy for Esophageal Cancer31
Tannic Acid Inhibits Non-small Cell Lung Cancer (NSCLC) Stemness by Inducing G0/G1 Cell Cycle Arrest and Intrinsic Apoptosis31
The Role of the Microbiome in Cancer and Therapy Efficacy: Focus on Lung Cancer27
Anatomical Predictors of Dosimetric Advantages for Deep-inspiration-breath-hold 3D-conformal Radiotherapy Among Women With Left Breast Cancer26
ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future Perspectives25
Alpha-type-1 Polarized Dendritic Cell-based Vaccination in Newly Diagnosed High-grade Glioma: A Phase II Clinical Trial24
Dendritic Cell-based Immunotherapy Pulsed With Wilms Tumor 1 Peptide and Mucin 1 as an Adjuvant Therapy for Pancreatic Ductal Adenocarcinoma After Curative Resection: A Phase I/IIa Clinical Trial24
Down-regulation of Glutathione Peroxidase 4 in Oral Cancer Inhibits Tumor Growth Through SREBP1 Signaling24
Advanced Stages and Increased Need for Adjuvant Treatments in Breast Cancer Patients: The Effect of the One-year COVID-19 Pandemic24
Inhibitors of Fatty Acid Synthesis and Oxidation as Potential Anticancer Agents in Colorectal Cancer Treatment24
Salvage Chemotherapy After Nivolumab for Recurrent or Metastatic Head and Neck Carcinoma24
0.036504983901978